Non-alcoholic steatohepatitis: identification, management, and referral pathways
The content on this page is intended for UK healthcare professionals only.
Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes
In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3287 December 2020
Assessment of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3288 December 2020
Management of pancreatic exocrine insufficiency (PEI) in primary care
In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
NON-2020-3289 December 2020
Management of common eye conditions: blepharitis
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.
Management of common eye conditions: conjunctivitis
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.
Management of common eye conditions: dry eye
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.
Management of common eye conditions: corneal and subtarsal foreign bodies
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.
Management of common eye conditions: chalazion (meibomian cyst)
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the presentation and management of chalazion (meibomian cyst).
Management of common eye conditions: corneal abrasion
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses the causes, symptoms, and treatment of corneal abrasion.
Promotional content
ClinOwl - A new resource for healthcare professionals
A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.
NICE Technology Appraisal 664: Liraglutide for managing overweight and obesity
The production and printing of this Guidelines summary card has been commissioned by Novo Nordisk Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK20SX00231
December 2020
NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation
The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/P/RZM/20-0016c October 2020
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.
DuoResp® Spiromax® (budesonide/formoterol)
This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020
COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014 V2.0
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011
Managing obesity in primary care
This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.
Primary care management of iron deficiency anaemia
This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
UK-HAE-FER-2000063
Anticholinergics and cognitive impairment in the treatment of overactive bladder
This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information
REG/2020/224 September 2020
Identifying and managing allergic rhinitis in the asthma population
This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.
Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.
Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for eligible patients with DVT or PE*
This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information
*Rivaroxaban is indicated for treatment of DVT and PE, and prevention of recurrent DVT and PE in adults.
PP-XAR-GB-1856 November 2020
Community Pharmacist Counselling Checklist for patients with NVAF initiated on Xarelto▼ (rivaroxaban)
This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information
PP-XAR-GB-1857 November 2020
Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for stroke prevention in patients with NVAF*
This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information
*Rivaroxaban is indicated for prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack.
PP-XAR-GB-1858 November 2020